Investigating the metabolic impact of the functional interaction of SIRT1 with SREBF1c and PPARα and insights into how NAD+ metabolism modulates adipocyte function could potentially lead to new avenues in developing therapeutics for obesity complications. This evidence concerns the gene SIRT1 and obesity due to melanocortin 4 receptor deficiency.